MICHAEL B WAX MD NPI 1255306296

NPI Details

Michael B Wax, MD is a hematology and oncology internal medicine in Berkeley Heights, NJ with 49 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Michael B Wax, MD NPI is 1255306296. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL COLLEGE OF PENNSYLVANIA
Graduation Year:1977

The provider's business location address is:

1 DIAMOND HILL RD
SUMMIT MEDICAL GROUP
BERKELEY HEIGHTS, NJ
ZIP 07922-104
Phone: (908) 277-8890
Fax: (908) 673-7390

The NPI 1255306296 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Red blood count, manual test (HCPCS:85044)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Blood test, clotting time (HCPCS:85610)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Unclassified drugs (HCPCS:J3490)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Bacterial urine culture (HCPCS:87088)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Bacterial colony count, urine (HCPCS:87086)
• Uric acid level, blood (HCPCS:84550)
• Total protein level, blood (HCPCS:84155)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Folic acid level, serum (HCPCS:82746)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Hemoglobin a1c level (HCPCS:83036)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Vitamin d-3 level (HCPCS:82306)

The enumeration date for this NPI number is 2/22/2006 and was last updated on 7/11/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: